Literature DB >> 33369098

Distress tolerance among emergency department patients in acute pain: Associations with substance use treatment.

Maria L Pacella-LaBarbara1, Caroline Maltese1, Madelyn McConaghy1, James Porter1, Michael L Young1, Brian Suffoletto2.   

Abstract

Managing acute pain in individuals with a history of substance use disorders (SUD) is complex. Distress tolerance (DT) (e.g., the ability to handle uncomfortable sensations) may serve as an ideal non-pharmacological intervention target in this population. Among 293 emergency department (ED) patients seeking treatment for pain (Mage  = 41; 42% Female; 43% Black), we examined rates of SUD treatment and DT, whether an objective DT task is feasible to conduct in the ED, and relationships between DT and SUD. Patients completed a self-report DT survey, an objective DT task, and brief surveys of pain, drug use, current or past SUD treatment, and depression/anxiety. Average DT was 18.50 (SD = 9.4) out of 50; patients with past or current SUD treatment (n = 43; 14.7%) reported lower DT than patients with no SUD treatment history (n = 250; 85.3%). Controlling for demographics, depression/anxiety, and pain severity, lower subjective DT (adjusted odds ratio [aOR] = 1.05) and objective DT (aOR = 1.02) was associated a current or past history or SUD treatment. Assessing subjective and objective DT in ED patients with acute pain is feasible; interventions aimed at boosting DT may improve outcomes among patients with acute pain and SUD.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  acute pain; distress tolerance; substance use

Mesh:

Year:  2021        PMID: 33369098      PMCID: PMC8713510          DOI: 10.1002/smi.3020

Source DB:  PubMed          Journal:  Stress Health        ISSN: 1532-3005            Impact factor:   3.454


  31 in total

Review 1.  Addiction motivation reformulated: an affective processing model of negative reinforcement.

Authors:  Timothy B Baker; Megan E Piper; Danielle E McCarthy; Matthew R Majeskie; Michael C Fiore
Journal:  Psychol Rev       Date:  2004-01       Impact factor: 8.934

Review 2.  Distress tolerance and psychopathological symptoms and disorders: a review of the empirical literature among adults.

Authors:  Teresa M Leyro; Michael J Zvolensky; Amit Bernstein
Journal:  Psychol Bull       Date:  2010-07       Impact factor: 17.737

3.  Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder.

Authors:  Benjamin J Morasco; Susan Gritzner; Lynsey Lewis; Robert Oldham; Dennis C Turk; Steven K Dobscha
Journal:  Pain       Date:  2010-12-23       Impact factor: 6.961

4.  Distress Intolerance and Prescription Opioid Misuse Among Patients With Chronic Pain.

Authors:  R Kathryn McHugh; Roger D Weiss; Marise Cornelius; Marc O Martel; Robert N Jamison; Robert R Edwards
Journal:  J Pain       Date:  2016-04-04       Impact factor: 5.820

5.  Prevalence and treatment of pain in EDs in the United States, 2000 to 2010.

Authors:  Hsien-Yen Chang; Matthew Daubresse; Stefan P Kruszewski; G Caleb Alexander
Journal:  Am J Emerg Med       Date:  2014-01-21       Impact factor: 2.469

6.  Initial RCT of a distress tolerance treatment for individuals with substance use disorders.

Authors:  Marina A Bornovalova; Kim L Gratz; Stacey B Daughters; Elizabeth D Hunt; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2011-10-07       Impact factor: 4.492

7.  An ultra-brief screening scale for anxiety and depression: the PHQ-4.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams; Bernd Löwe
Journal:  Psychosomatics       Date:  2009 Nov-Dec       Impact factor: 2.386

Review 8.  Iatrogenic addiction in patients treated for acute or subacute pain: a systematic review.

Authors:  Ajay D Wasan; Darin J Correll; Igor Kissin; Sarah O'Shea; Robert N Jamison
Journal:  J Opioid Manag       Date:  2006 Jan-Feb

9.  Changes in distress intolerance and treatment outcome in a partial hospital setting.

Authors:  R Kathryn McHugh; Sarah J Kertz; Rachel B Weiss; Arielle R Baskin-Sommers; Bridget A Hearon; Thröstur Björgvinsson
Journal:  Behav Ther       Date:  2013-11-13

10.  Persistence on a stress-challenge task before initiating buprenorphine treatment was associated with successful transition from opioid use to early abstinence.

Authors:  David R Strong; Richard A Brown; Meredith Sims; Debra S Herman; Bradley J Anderson; Michael D Stein
Journal:  J Addict Med       Date:  2012-09       Impact factor: 3.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.